Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTAMedical - Care Facilities
+$0.00 today
- Market cap
- $445.55M
- Beta
- 0.00
- P/E (TTM)
- 414.6
- EPS (TTM)
- $0.07
Volume 0.00M
Average 0.87M
MCTA Total Current Liabilities
All obligations due within one year.
Charming Medical Limited Class A Ordinary SharesNASDAQ: MCTA
Total Current Liabilities · Q4 FY2024 · quarter ended Mar 2025
Total current liabilities falls 15.8% from a year ago
Total current liabilities stood at $4.95M at the end of Q4 FY2024, down 15.8% from a year earlier.
Context
- Total current liabilities amounted to 92.4% of total assets at the end of Q4 FY2024, down 28.0 pp from a year earlier.
- Total current liabilities increased in 0 of the last 2 fiscal years.
- FY2024 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether total current liabilities keeps falling in the next quarterly balance sheet after a -15.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2024
- 4.95M USD
- Year-over-year change
- -15.8%
- 2-year CAGR
- -16.9%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 4.95M | -15.8% |
| FY2023 | 2024-03-31 | 5.88M | -18.0% |
| FY2022 | 2023-03-31 | 7.17M | — |
Total Current Liabilities vs competitors
How MCTA compares with its peers on the latest reported figures
- MCTA's Mar 2025 total current liabilities of $4.95M is the lowest of the 10 companies compared; the peer median is $36.01M.
- Its year-over-year change of -15.8% is the 9th highest of 10, against a peer median of +15.4%.
- Total current liabilities amounts to 92.4% of total assets for MCTA, versus a peer median of 13.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $1.27B | -7.4% | +26.2% | 84.5% | |
| Mar 2026 | $251.7M | +44653.7% | +770.1% | 40.5% | |
| Mar 2026 | $90.57M | -16.9% | -34.1% | 20.1% | |
| Mar 2026 | $79.35M | +33.3% | +33.7% | 47.2% | |
| Mar 2026 | $36.01M | +1.7% | -14.0% | 13.2% | |
| Mar 2026 | $35.94M | +7.1% | +24.0% | 13.7% | |
| Mar 2026 | $27.38M | +20.4% | +15.1% | 9.0% | |
| Feb 2026 | $12.34M | +15.4% | -4.6% | 8.4% | |
| Mar 2026 | $10.7M | +102.3% | -9.4% | 8.6% | |
MCTACharming Medical Limited Class A Ordinary Shares | Mar 2025 | $4.95M | -15.8% | — | 92.4% |
| Peer median (excluding MCTA) | $36.01M | +15.4% | +15.1% | 13.7% | |
Competitors are the stored peer set for MCTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTA
Intrinsic Alpha fair value
Locked
Current Price
$29.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.